Drug
Fosigotifator
Fosigotifator is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Completion Rate
0%(0/2)
Active Trials
2(40%)
Terminated
2(40%)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_1
3
60%
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Terminated(2)
Other(1)
Detailed Status
Terminated2
Recruiting1
unknown1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
0.0%
Most Advanced
Phase 1
Trials by Phase
Phase 13 (75.0%)
N/A1 (25.0%)
Trials by Status
recruiting120%
unknown120%
active_not_recruiting120%
terminated240%
Recent Activity
2 active trials
Showing 5 of 5
active_not_recruitingnot_applicable
Single Patient Investigational Treatment for Cree Leukoencephalopathy
NCT07300397
unknown
Expanded Access to Fosigotifator
NCT06594016
recruitingphase_1
An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
NCT05757141
terminatedphase_1
A Study to Assess Adverse Events of Fosigotifator (ABBV-CLS-7262) in Adults With Major Depressive Disorder
NCT06618118
terminatedphase_1
A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic Lateral Sclerosis
NCT04948645
Clinical Trials (5)
Showing 5 of 5 trials
NCT07300397Not Applicable
Single Patient Investigational Treatment for Cree Leukoencephalopathy
NCT06594016
Expanded Access to Fosigotifator
NCT05757141Phase 1
An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
NCT06618118Phase 1
A Study to Assess Adverse Events of Fosigotifator (ABBV-CLS-7262) in Adults With Major Depressive Disorder
NCT04948645Phase 1
A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic Lateral Sclerosis
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5